Significant Developments in the Application of SKRM Technology

The MetaProteomics researchers have been productive contributors to the body of science, and you will find most of our articles contain the concept of the emerging profile of how SKRMs and other nutritional ingredients deliver value in the prevention and management of certain chronic illnesses. Some significant scientific develops include the following:

If you are interested in a potential partnership with MetaProteomics, please Contact Us.

The Discovery of Reduced Iso-Alpha Acids

In 2002, the MetaProteomics research team began searching for effective anti-inflammatory ingredients with superior safety in comparison to conventional products. In their quest, they screened 100s of molecules from Humulus lupulus, or hops. The result was the identification of a class of hops molecules called reduced iso-alpha acids (RIAA). One of the most intriguing features of RIAA is that it did not directly inhibit cyclooxygenase-1 (COX-1) or cyclooxygenase-2 (COX-2) like common anti-inflammatory products. By not directly inhibiting COX-1 and COX-2, RIAA avoids the well-known potential gastrointestinal, cardiovascular, and renal side effects associated with anti-inflammatories. This helped to frame RIAA as a new class of inflammatory agents. These results were published proceedings from the 1st International Symposium on Humulus.

[Matthew Tripp, PhD, Gary Darland, PhD, Daniel Lukaczer, Jeffrey S. Bland PhD. Hop and modified hop extracts have potent in vitro anti-inflammatory properties. Published Proceedings from 1st International Symposium on Humulus. Editors K.E. Hummer and J.A. Henning Acta Horiculturae 668, ISHS 2005.]